Media & Press
Dr. Wong contributes to public and professional discourse on retinal disease, high myopia, and surgical innovation — through broadcast media, print, conferences, and public health campaigns.
Featured
Recent highlights
Channel NewsAsia
Dr. Wong spoke to Channel NewsAsia about the structural consequences of high myopia — moving the public conversation beyond spectacle prescriptions to the retinal complications that affect a growing proportion of Singapore's adult population. The segment covered myopic macular degeneration, the role of annual surveillance, and what parents can do to slow progression in children.
The Straits Times
Feature article on retinal emergencies — explaining the clinical distinction between benign vitreous floaters and the warning signs of retinal tear or detachment.
Healthier SG Podcast
A deep-dive conversation on the long-term ocular consequences of childhood myopia — and why the myopia control conversation needs to start much earlier.
Press & Online
Selected coverage
高度近视的隐形代价
Mandarin-language feature on the silent retinal complications of high myopia — reaching Singapore's Chinese-speaking community with evidence-based information on surveillance and prevention.
Retinal detachment: the eye emergency most people don't know to fear
Patient education article explaining warning signs, risk factors in myopes, and why time-to-surgery is the most important determinant of visual outcome.
Myopia in Singapore: expert perspectives on prevention and control
Contributing expert for the Ministry of Health's public-facing myopia resource hub — providing clinical guidance on atropine therapy, orthokeratology, and outdoor time recommendations.
Eye health after 50: what Singaporeans need to know
Live radio interview on age-related retinal conditions — covering macular degeneration, floaters, and when to seek urgent assessment.
Eden Ophthalmic: taking sustained drug delivery from bench to clinic
Profile of Dr. Wong's co-founded ophthalmic biotech startup, covering the Phase I/II clinical trial of its sustained-release intravitreal drug delivery technology.
AI-based diabetic retinopathy screening achieves diagnostic parity
Press coverage of the Lancet Digital Health publication from the Singapore Eye Research Institute — for which Dr. Wong is a contributing author — validating autonomous AI screening for diabetic retinopathy.
International Conferences
Speaking engagements
Asia-Pacific Academy of Ophthalmology (APAO)
Surgical management of myopic foveoschisis: when to operate and what to expect
Tokyo, Japan
Singapore National Eye Centre Annual Symposium
Late IOL dislocation: risk stratification and surgical decision-making
Singapore
American Academy of Ophthalmology (AAO) Annual Meeting
12-year longitudinal outcomes of myopic retinal detachment: lessons from the SEED cohort
San Francisco, USA
Ophthalmological Society of Singapore (OSS) Annual Congress
Phacoemulsification-vitrectomy combined surgery: technique and outcomes update
Singapore
World Ophthalmology Congress (WOC)
Sustained-release intravitreal drug delivery: from concept to Phase I/II clinical trial
Dubai, UAE
International Society of Refractive Surgery (ISRS)
Retinal risk after LASIK in high myopia: what the refractive surgeon must know
Chicago, USA
Asia-Pacific Vitreo-Retina Society (APVRS)
Biometry-based scleral buckling: improving anatomical outcomes in myopic retinal detachment
Virtual (COVID-19)
WHO/IAPB Myopia Management Expert Panel
Contributing expert — International evidence-based guidelines on myopia control
Geneva (Virtual)
Dr. Wong is available for comment, interview, and expert consultation on topics relating to retinal surgery, high myopia, macular disease, and ophthalmic innovation. He presents in English and Mandarin.
Clinic
Languages
English · Mandarin
Based in
Singapore · available for regional travel